PRODUCT LIST
_________________________
At RAFARM, we are highly specialized in the research, development and supply of a wide range of complex pharmaceutical products. We focus on sterile forms, in particular ophthalmic products: solutions, suspensions and emulsions, and complex injectable products.
We work closely with our customers every step of the way, from the lab to commercial scale production. We make full use of the expertise of our highly skilled and specialized teams to provide you with integrated CDMO solutions. We are ready to take on your project.
| PRODUCT NAME | FORM | STRENGTH | THERAPEUTIC AREA | STATUS |
|---|---|---|---|---|
| AMICAKIN | Sol. Inj. /Sol. Inf. 2 ml vial | 500 mg/2ml | Anti-infective | Available EU CTD |
| APIXABAN | Film-coated tablets | 2.5 and 5 mg | Antithrombotic agent | Available EU CTD |
| BIMATOPROST | Eye Drops solution 3 ml bottle | 0.3 mg/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| BIMATOPROST | Eye Drops solution 3 ml bottle | 0.1 mg/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| BIMATOPROST + TIMOLOL | Eye Drops solution 3 ml bottle | (0.3 mg+5mg)/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| BRIMONIDINE | Eye Drops solution 5 ml bottle | 2mg/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| BRIMONIDINE + TIMOLOL | Eye Drops solution 5 ml bottle | (2mg + 5mg)/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| BRINZOLAMIDE/BRIMONIDINE *NEW* | Eye Drops Suspension 5ml bottle | (10mg+2mg)/ml | Glaucoma & Ocular Hypertension | Q2 2026 |
| BROMFENAC *NEW* | Eye Drops solution 5ml bottle | 0.9mg/ml | Treatment of inflammation and pain after cataract surgery | Q1 2024 |
| CLOPIDOGREL BESILATE | Film-coated Tablets | 75 mg/tab. | Anti-thrombotic | Available EU CTD |
| CIPROFLOXACIN + DEXAMETHASONE *NEW* | Ear Drops Suspension | (3mg +1mg)/ml | Acute middle ear infection (otitis media) and outer ear infection (acute otitis externa) | Available EU CTD |
| DEXAMETHASONE | Soluble Tablets | 2 mg/tab. | Glucocorticoid Therapy | Available EU CTD |
| DEXAMETHASONE | Soluble Tablets | 4 mg/tab | Glucocorticoid Therapy | Available EU CTD |
| DEXAMETHASONE | Soluble Tablets | 8 mg/tab | Glucocorticoid Therapy | Available EU CTD |
| DEXAMETHASONE | Soluble Tablets | 10 mg/tab | Glucocorticoid Therapy | Available EU CTD |
| DEXAMETHASONE | Soluble Tablets | 20 mg/tab | Glucocorticoid Therapy | Available EU CTD |
| DEXAMETHASONE PRESERVATIVE FREE | Eye Drops solution 5 ml bottle | 1 mg/ml | Treatment of inflammatory conditions of the anterior segment of the eye | Available EU CTD |
| DIFLUPREDNATE *NEW* | Eye Drops solution 5ml bottle | 0.5 mg/ml | Inflammation and pain associated with ocular surgery. Anterior uveitis | NOT EU available |
| DORZOLAMIDE | Eye Drops solution 5ml bottle | 20 mg/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| DORZOLAMIDE + TIMOLOL | Eye Drops solution 5ml bottle | (20 mg+5 mg)/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| DUTASTERIDE | Soft Gel Capsules | 0.5 mg/caps | Benign Prostatic Hyperplasia | Available EU CTD |
| ELETRIPTAN | Film-coated Tablets | 20 mg/tab | Migraine Treatment | Available EU CTD |
| ELETRIPTAN | Film-coated Tablets | 40 mg/tab | Migraine Treatment | Available EU CTD |
| ELETRIPTAN | Film-coated Tablets | 80 mg/tab | Migraine Treatment | Available EU CTD |
| EZETIMIBE | Tablets | 10 mg/tab | Primary Hypercholesterolaemia | Available EU CTD |
| FERRIC CARBOXYMALTOSE *NEW* | Sol. Inj 2ml, 10ml, 20ml vial | 50mg/ml | Iron Deficiency | Q4 2024 |
| ILOPROST | Conc. Sol. Inf. 1 ml, 2.5 ml amp. | 20 mcg/ml | Severe peripheral arterial occlusive disease (PAOD) | Available EU CTD |
| ILOPROST | Conc. Sol. Inf. 0.5 ml, 1 ml amp. | 100 mcg/ml | Severe peripheral arterial occlusive disease (PAOD) | Available EU CTD |
| ILOPROST | Νebulizer Sol. 1 & 2 ml amp. | 10 mcg/ml | Pulmonary hypertension | Available EU CTD |
| ILOPROST | Nebulizer Sol. 1ml amp. | 20 mcg/ml | Pulmonary hypertension | Available EU CTD |
| IRON SUCROSE COMPLEX | Sol. Inj. /Conc. Sol. Inf. 5 ml amp. | 20mg/ml | Iron Deficiency | Available EU CTD |
| LATANOPROST | Eye Drops solution 2.5 ml bottle | 50 mcg/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| LATANOPROST PRESERVATIVE FREE *NEW* | Eye Drops solution 0,2 ml Single Unit Dose, Box of 30 Unit Dose (2 strips of 5 Unit Dose in aluminium sachet) | 50mcg/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| LATANOPROST + TIMOLOL | Eye Drops solution 2.5 ml bottle | (50 mcg+5mg)/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| LATANOPROSTENE BUNOD *NEW* | Eye Drops solution 2,5ml and 5ml bottle | 0.24 mg/ml | Glaucoma & Ocular Hypertension | Q4 2024 US dossier |
| LEVOFLOXACIN | Eye Drops solution 5 ml bottle | 5mg/ml | Topical treatment of bacterial external ocular infections | Available EU CTD |
| LEVOFLOXACIN PRESERVATIVE FREE | Eye Drops solution 5 ml bottle | 5 mg/ml | Topical treatment of bacterial external ocular infections | Available EU CTD |
| MOXIFLOXACIN *NEW* | Eye Drops solution 3ml bottle | 5 mg/ml | Ocular infection | Dossier available |
| OLOPATADINE | Eye Drops solution 5 ml bottle | 1 mg/ml | Allergic Conjunctivitis | Available EU CTD |
| PARICALCITOL | Soft Gel Capsules | 1 mcg/cap | Secondary Hyperparathyroidism | Available EU CTD |
| PARICALCITOL | Soft Gel Capsules | 2 mcg/cap | Secondary Hyperparathyroidism | Available EU CTD |
| PARICALCITOL | Soft Gel Capsules | 4 mcg/cap | Secondary Hyperparathyroidism | Available EU CTD |
| PARICALCITOL | Sol. Inj. 1ml vial or amp | 2 mcg/ml | Secondary Hyperparathyroidism | Available EU CTD |
| PARICALCITOL | Sol. Inj. 1ml vial or amp | 5 mcg/ml | Secondary Hyperparathyroidism | Available EU CTD |
| PARICALCITOL | Sol. Inj. 2ml vial or amp | 5 mcg/ml | Secondary Hyperparathyroidism | Available EU CTD |
| PALONOSETRON | Sol. Inj. 5 ml vial | 250 mcg/5ml | Acute Nausea & Vomiting | Available EU CTD |
| ROSUVASTATIN CALCIUM | Film-coated Tablets | 5 mg/tab | Hypercholesterolaemia &Prevention of Cardiovascular Events | Available EU CTD |
| ROSUVASTATIN CALCIUM | Film-coated Tablets | 10 mg/tab | Hypercholesterolaemia &Prevention of Cardiovascular Events | Available EU CTD |
| ROSUVASTATIN CALCIUM | Film-coated Tablets | 20 mg/tab | Hypercholesterolaemia &Prevention of Cardiovascular Events | Available EU CTD |
| SODIUM CROMOGLICATE PRESERVATIVE FREE | Eye Drops solution 5 ml bottle | 20 mg/ml | Relief and treatment of seasonal and perennial allergic conjunctivitis | Available EU CTD |
| SODIUM CROMOGLICATE PRESERVATIVE FREE | Eye Drops solution 10 ml bottle | 20 mg/ml | Relief and treatment of seasonal and perennial allergic conjunctivitis | Available EU CTD |
| TAFLUPROST PRESERVATIVE FREE *NEW* | Eye Drops solution 5 ml bottle | 0,015mg/ml | Glaucoma & Ocular Hypertension | Q4 2024 |
| TAFLUPROST/ TIMOLOL PRESERVATIVE FREE *NEW* | Eye Drops solution 5 ml bottle | (0,015mg+5mg)/ml | Glaucoma & Ocular Hypertension | Q4 2024 |
| TICAGRELOR | Film-coated tablets | 60 and 90 mg | Antithrombotic agent | Available EU CTD |
| TOBRAMYCIN + DEXAMETHASONE | Eye Drops solution 5 ml bottle | (3mg + 1mg)/ml | Intraocular inflammation & ocular surface bacterial Available EU CTD and perennial allergic conjunctivitis | Available EU CTD |
| TRAVOPROST | Eye Drops solution 2.5 ml bottle | 40 mcg/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| TRAVOPROST + TIMOLOL | Eye Drops solution 2.5 ml bottle | (40mcg+5mg)/ml | Glaucoma & Ocular Hypertension | Available EU CTD |
| ZOLEDRONIC ACID | Conc. Sol. Inf. 5 ml vial | 4 mg/5 ml | Skeletal Related Events in Advanced Malignancies & Tumour-Induced Hypercalcaemia | Available EU CTD |
OPTHALMICS
INJECTABLES
ORALS
OTHERS
